Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Amir Tahmasb Fathi, M.D.

Concepts (413)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Amir Fathi's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Amir Fathi has written about over time.
Protein Kinase Inhibitors, 15 publications between 2009 and 2017, average publication date January 2014. fms-Like Tyrosine Kinase 3, 15 publications between 2009 and 2021, average publication date July 2014. Glutarates, 5 publications between 2012 and 2018, average publication date March 2015. Antineoplastic Agents, 28 publications between 2008 and 2024, average publication date June 2016. Cytarabine, 14 publications between 2009 and 2023, average publication date January 2017. Mutation, 37 publications between 2011 and 2023, average publication date March 2017. Myelodysplastic Syndromes, 13 publications between 2012 and 2024, average publication date June 2017. Hematopoietic Stem Cell Transplantation, 20 publications between 2012 and 2023, average publication date June 2017. Leukocytosis, 4 publications between 2012 and 2020, average publication date June 2017. Isocitrate Dehydrogenase, 28 publications between 2012 and 2023, average publication date March 2018. Leukemia, Myeloid, Acute, 96 publications between 2009 and 2024, average publication date May 2018. Antineoplastic Combined Chemotherapy Protocols, 25 publications between 2012 and 2023, average publication date September 2018. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 8 publications between 2013 and 2022, average publication date October 2018. Enzyme Inhibitors, 11 publications between 2017 and 2021, average publication date June 2019. Aminopyridines, 6 publications between 2017 and 2021, average publication date September 2019. Triazines, 6 publications between 2017 and 2021, average publication date September 2019. Azacitidine, 7 publications between 2012 and 2023, average publication date September 2019. Leukemia, Myelomonocytic, Chronic, 3 publications between 2013 and 2024, average publication date April 2020. Myeloproliferative Disorders, 5 publications between 2015 and 2024, average publication date March 2021.

To see the data from this visualization as text, click here.
Fathi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (413)
Explore
_
Co-Authors (146)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.